News

(Available in Chinese only)

(Available in Chinese only)

Sincere gratitude to all the volunteers participating in the study related to biological therapies targeting eosinophilic asthma earlier in 2019 (CTC1843), leading by the University of Hong Kong Clinical Trials Centre (HKU-CTC). We are thrilled to announce that the research data of the Phase III Study has already been submitted to the National Medical Products Administration (NMPA) for evaluation. This will certainly bring hopes to severe asthma patients if approval is granted by the NMPA eventually!

(Available in Chinese only)

(Available in Chinese only)

HKU-CTC has been walking together with Hong Kong in the past 25 years in advancing human healthcare. To commemorate this milestone, we held the silver jubilee celebration event earlier. The event brought together government officials, academic and industry representatives, as well as our dedicated colleagues in clinical research, with some 300 attendees. It was a joyous occasion started with speeches from Professor Richard Wong, Acting President & Vice-Chancellor of HKU, Dr. Stephen Wong, Head of Chief Executive’s Unit of HKSAR Government, Mr. Henry Fan, Chairman of Hospital Authority and Professor Leung Wai-Keung, HKU-CTC’s Chief Director, who commended the center's contributions to healthcare innovation in Hong Kong and its commitment to societal well-being. We also took the opportunity to express our appreciation to 10 colleagues who have been of service with HKU-CTC for 5 to 20 years, and congratulate our 5 trainees for their successful completion of our trainee programme during 2022-23. Let's take a moment to relive the highlights of this memorable evening!

(Available in Chinese only)

(Available in Chinese only)

(Available in Chinese only)

The year 2023 was a year full of challenges, but HKU-CTC never stopped its efforts. We hosted the Clinical Research Governance World Conference and International Clinical Trial Center Network - ICN Symposium earlier. The theme was "Clinical Research Success through Good Governance" and it brought over 250 representatives on-site from government agencies, research institutions, and the biomedical industry from around the world to discuss the latest trends in clinical trial governance. We were honored to have Professor Lo Chung-Mau, Secretary for Health, Mr. Li Chuang, Deputy Director of Shenzhen Municipal Health Commission, Professor Lau Chak-Sing, Dean of Medicine at The University of Hong Kong, and Dr. Christiane Blankenstein, Chairperson of International Clinical Trials Center Network, delivered speeches at the opening ceremony, making it a lively and momentous occasion. Now, let's take a look at the highlights of that exciting day!